NIH Raises Concerns About Foreign Influence in Biomedical Research
Catherine Offord | Feb 8, 2019
Information made public by US Senator Chuck Grassley reveals that a handful of allegations have recently been referred to federal investigators.
US Senators Call for International Guidelines for Germline Editing
US Senators Call for International Guidelines for Germline Editing
In the wake of reports of CRISPRed babies born in China, a bipartisan resolution “opposes the experiments that resulted in pregnancies using genome-edited human embryos.”
In the wake of reports of CRISPRed babies born in China, a bipartisan resolution “opposes the experiments that resulted in pregnancies using genome-edited human embryos.”
How the Midterm Elections’ Results Affect Science
Ashley P. Taylor | Nov 7, 2018
The Democrats’ takeover of the House inspires hope for science-based policies, but voters struck down several ballot initiatives to counteract climate change.
Scientists Win First-Time Runs for Congress, Senate
Catherine Offord | Nov 7, 2018
The midterm elections flip several House seats in favor of Democratic candidates with STEM backgrounds.
Congress Considers Endangered Species Act Amendments
Jef Akst | Sep 27, 2018
Opponents of the proposal call the changes a “wildlife extinction package.”
US Senate Passes Spending Bill Granting NIH $39.1 Billion
Sukanya Charuchandra | Aug 27, 2018
Alzheimer’s disease will receive $2.3 billion, the biggest chunk of change devoted to one of the NIH’s various interests.
Trump Nominates Scott Hutchins for USDA Top Scientist
Sukanya Charuchandra | Jul 18, 2018
A pesticide industry leader, Hutchins was formerly president of the Entomological Society of America.
Senate, House Propose Funding Boosts for US Science Agencies
Sukanya Charuchandra | Jun 17, 2018
NASA, NSF, and NIH are expected to receive higher financial backing for the 2019 fiscal year, going above and beyond the President’s proposed budget.
NIH Funding Boost Clears Senate Committee
Shawna Williams | Sep 6, 2017
The proposed spending increase in the draft bill is more generous than that in the House version.
Right-to-Try Bill Passes the Senate
Catherine Offord | Aug 4, 2017
The legislation removes restrictions for seriously ill patients to access experimental treatments that have not received FDA approval.